
Coral Genomics
New clinical tests for managing autoimmune treatments.
Informazioni
Descrizione dell’azienda in inglese
Coral integrates molecular, functional, and clinical factors to create new clinical laboratory tests that predict optimal treatments for autoimmune diseases.
We have also identified a unique subpopulation of patients who do not respond to current therapies and are working towards addressing this unmet medical need.
Temi
- Sede
- San Francisco, CA, USA
- Team
- 5 dipendenti
- Batch YC
- Summer 2018
- Stato
- Acquisita
- Fase
- Fase iniziale





